X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with BAJAJ CORP - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs BAJAJ CORP - Comparison Results

BAJAJ CORP 
   Change

Bajaj Corp. Limited (BCL) is a leading producer of hair oils. It is part of the Shishir Bajaj Group of companies and subsidiary of Bajaj Consumer Care Limited (BCCL). The legacy of BCL began in 1953 when Bajaj Sevashram was established to market and ... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES BAJAJ CORP AMAR REMEDIES/
BAJAJ CORP
 
P/E (TTM) x -0.5 33.2 - View Chart
P/BV x 0.1 14.5 0.4% View Chart
Dividend Yield % 0.0 2.4 -  

Financials

 AMAR REMEDIES   BAJAJ CORP
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
BAJAJ CORP
Mar-17
AMAR REMEDIES/
BAJAJ CORP
5-Yr Chart
Click to enlarge
High Rs164438 37.4%   
Low Rs86340 25.3%   
Sales per share (Unadj.) Rs261.654.0 484.2%  
Earnings per share (Unadj.) Rs17.414.8 117.6%  
Cash flow per share (Unadj.) Rs22.315.2 147.0%  
Dividends per share (Unadj.) Rs011.50 0.0%  
Dividend yield (eoy) %03.0 0.0%  
Book value per share (Unadj.) Rs100.733.5 300.6%  
Shares outstanding (eoy) m26.16147.50 17.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.57.2 6.6%   
Avg P/E ratio x7.226.3 27.3%  
P/CF ratio (eoy) x5.625.7 21.8%  
Price / Book Value ratio x1.211.6 10.7%  
Dividend payout %077.7 0.0%   
Avg Mkt Cap Rs m3,27057,400 5.7%   
No. of employees `000NA0.5 0.0%   
Total wages/salary Rs m163614 26.6%   
Avg. sales/employee Rs ThNM15,208.0-  
Avg. wages/employee Rs ThNM1,171.6-  
Avg. net profit/employee Rs ThNM4,164.9-  
INCOME DATA
Net Sales Rs m6,8447,969 85.9%  
Other income Rs m21394 5.3%   
Total revenues Rs m6,8658,363 82.1%   
Gross profit Rs m1,1312,636 42.9%  
Depreciation Rs m12853 240.6%   
Interest Rs m39810 3,864.1%   
Profit before tax Rs m6262,966 21.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-184 27.2%   
Tax Rs m121600 20.2%   
Profit after tax Rs m4552,182 20.8%  
Gross profit margin %16.533.1 50.0%  
Effective tax rate %19.320.2 95.5%   
Net profit margin %6.627.4 24.3%  
BALANCE SHEET DATA
Current assets Rs m4,9044,259 115.2%   
Current liabilities Rs m3,581788 454.4%   
Net working cap to sales %19.343.6 44.4%  
Current ratio x1.45.4 25.3%  
Inventory Days Days12419 638.7%  
Debtors Days Days10013 797.2%  
Net fixed assets Rs m1,6891,616 104.5%   
Share capital Rs m262148 177.6%   
"Free" reserves Rs m2,3584,794 49.2%   
Net worth Rs m2,6354,942 53.3%   
Long term debt Rs m5070-   
Total assets Rs m6,8625,895 116.4%  
Interest coverage x2.6289.0 0.9%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.4 73.8%   
Return on assets %12.437.2 33.4%  
Return on equity %17.344.2 39.1%  
Return on capital %31.056.5 54.9%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m27330 925.4%   
Fx outflow Rs m27 29.9%   
Net fx Rs m27123 1,188.6%   
CASH FLOW
From Operations Rs m-3132,120 -14.7%  
From Investments Rs m-489-153 318.4%  
From Financial Activity Rs m769-2,000 -38.4%  
Net Cashflow Rs m-33-33 98.2%  

Share Holding

Indian Promoters % 25.5 66.9 38.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 1.6 564.4%  
FIIs % 0.0 24.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 7.1 919.7%  
Shareholders   13,061 19,219 68.0%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   ARCHIES LTD  MARICO LTD  GODREJ INDUSTRIES  LINC PEN & PLASTICS LTD  P&G HYGIENE  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Opens Marginally Higher; ONGC Rallies 6.3%(09:30 am)

Asian stock markets traded on a mixed note in morning trade as market participants kept an eye on political developments in the U.S. after a government shutdown began last week.

Related Views on News

Bajaj Corp: Slow Recovery from GST Implementation (Quarterly Results Update - Detailed)

Nov 10, 2017

A slow recovery from GST implementation and strained wholesale volumes puts pressure on Bajaj Corp's revenues.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS